Skip to main content
Northwestern University Feinberg School of Medicine
Center for Arrhythmia Research

Publications

  1. Al-Khalil Z, Attarian H, Dunietz GL, Gavidia Romero R, Knutson K, Johnson DA  Sleep health inequities in vulnerable populations: Beyond sleep deserts.  Sleep Med X  2024 Dec;7:100110. pii:100110
  2. Doiron JE, Xia H, Yu X, Nevins AR, LaPenna KB, Sharp TE, Goodchild TT, Allerton TD, Elgazzaz M, Lazartigues E  et al.  Adjunctive therapy with an oral H2S donor provides additional therapeutic benefit beyond SGLT2 inhibition in cardiometabolic heart failure with preserved ejection fraction.  Br J Pharmacol  2024 Nov;181(21):4294-4310. doi:10.1111/bph.16493
  3. Van Crombrugge E, Ren X, Glorieux S, Zarak I, Van den Broeck W, Bachert C, Zhang N, Van Zele T, Kim D, Smith GA  et al.  The alphaherpesvirus gE/gI glycoprotein complex and proteases jointly orchestrate invasion across the host's upper respiratory epithelial barrier.  mBio  2024 Oct 09;:e0187324. doi:10.1128/mbio.01873-24
  4. Peek N, Hindricks G, Akbarov A, Tijssen JGP, Jenkins DA, Kapacee Z, Parkes LM, van der Geest RJ, Longato E, Sprague D  et al.  Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts.  Eur Heart J  2024 Oct 08;. pii:ehae326
  5. Fakhari H, Scherr CL, Moe S, Hoell C, Smith ME, Rasmussen-Torvik LJ, Chisholm RL, McNally EM  From Calculation to Communication: Using Risk Score Calculators to Inform Clinical Decision Making and Facilitate Patient Engagement.  Med Decis Making  2024 Oct 08;:272989X241285036. doi:10.1177/0272989X241285036
  6. Huang Y, Shan Y, Zhang W, Printzis C, Pesce L, Maeser D, Stanhope C, Stranger BE, Huang RS  Sex differences in the molecular profile of adult diffuse glioma are shaped by IDH status and tumor microenvironment.  Neuro Oncol  2024 Oct 05;. pii:noae207
  7. Fudim M, Borlaug BA, Mohan RC, Price MJ, Fail P, Goyal P, Hummel SL, Zirakashvili T, Shaburishvili T, Patel RB  et al.  Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: The REBALANCE-HF Randomized Clinical Trial.  JAMA Cardiol  2024 Oct 02;. pii:e242612
  8. Kitzman DW, Voors AA, Mentz RJ, Lewis GD, Perl S, Myte R, Kaguthi G, Sjöström CD, Källgren C, Shah SJ  Verinurad Plus Allopurinol for Heart Failure With Preserved Ejection Fraction: The AMETHYST Randomized Clinical Trial.  JAMA Cardiol  2024 Oct 01;9(10):892-900. pii:e242435
  9. Thangada ND, Sinha A, Ning H, Paluch A, Zhong VW, Allen NB, Carnethon MR, Wilkins JT, Lloyd-Jones DM, Khan SS  Association Between Cardiovascular Health and Lifetime Risk of Heart Failure: A Pooled Cohort Analysis.  JACC Heart Fail  2024 Oct;12(10):1788-1790. doi:10.1016/j.jchf.2024.06.015
  10. Hanauer SB, Sands BE, Schreiber S, Danese S, Kłopocka M, Kierkuś J, Kulynych R, Gonciarz M, Sołtysiak A, Smoliński P  et al.  Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY).  Gastroenterology  2024 Oct;167(5):919-933. doi:10.1053/j.gastro.2024.05.006
  11. Nisivaco S, McCarthy PM, Kruse J, Andre AC, Zhao M, Thomas JD  Late results of chord transfer and other techniques for anterior leaflet repair without neochords.  J Thorac Cardiovasc Surg  2024 Oct;168(4):1045-1056.e3. doi:10.1016/j.jtcvs.2023.05.047
  12. Shah SJ, Rigolli M, Javidialsaadi A, Patel RB, Khadra S, Goyal P, Little S, Wever-Pinzon O, Owens AT, Skali H  et al.  Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF Trial.  JAMA Cardiol  2024 Sep 30;. doi:10.1001/jamacardio.2024.3810
  13. Chimura M, Petrie MC, Schou M, Martinez FA, Henderson AD, Claggett BL, Desai AS, Kolkhof P, Viswanathan P, Lage A  et al.  Finerenone Improves Outcomes in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction Irrespective of Age: A Prespecified Analysis of FINEARTS-HF.  Circ Heart Fail  2024 Sep 29;. doi:10.1161/CIRCHEARTFAILURE.124.012437
  14. Docherty KF, Henderson AD, Jhund PS, Claggett BL, Desai AS, Mueller K, Viswanathan P, Scalise A, Lam CSP, Senni M  et al.  Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure with Mildly Reduced and Preserved Ejection Fraction: a Prespecified Analysis of The FINEARTS-HF Trial.  Circulation  2024 Sep 29;. doi:10.1161/CIRCULATIONAHA.124.072011
  15. Vaduganathan M, Claggett BL, Kulac IJ, Miao ZM, Desai AS, Jhund PS, Henderson AD, Brinker M, Lay-Flurrie J, Viswanathan P  et al.  Effects of the Non-Steroidal MRA Finerenone with and without Concomitant SGLT2 Inhibitor Use in Heart Failure.  Circulation  2024 Sep 28;. doi:10.1161/CIRCULATIONAHA.124.072055
  16. Vaduganathan M, Claggett BL, Desai AS, Jhund PS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B  et al.  Estimated Long-Term Benefits of Finerenone in Heart Failure: A Prespecified Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial.  JAMA Cardiol  2024 Sep 27;. doi:10.1001/jamacardio.2024.3782
  17. Vaduganathan M, Claggett BL, Desai AS, Jhund PS, Lam CSP, Senni M, Shah SJ, Voors AA, Zannad F, Pitt B  et al.  Time to Significant Benefit of Finerenone in Patients With Heart Failure.  J Am Coll Cardiol  2024 Sep 26;. pii:S0735-1097(24)08512-7
  18. Graffy PM, Sunderraj A, Visa MA, Miller CH, Barrett BW, Rao S, Camilleri SF, Harp RD, Li C, Brenneman A  et al.  Methodological Approaches for Measuring the Association Between Heat Exposure and Health Outcomes: A Comprehensive Global Scoping Review.  Geohealth  2024 Sep;8(9):e2024GH001071. pii:e2024GH001071
  19. Desai AS, Vaduganathan M, Claggett BL, Kulac IJ, Jhund PS, Cunningham J, Borentain M, Lay-Flurrie J, Viswanathan P, Rohwedder K  et al.  Finerenone in Patients With a Recent Worsening Heart Failure Event: The FINEARTS-HF Trial.  J Am Coll Cardiol  2024 Sep 25;. pii:S0735-1097(24)08452-3
  20. Khan SS, Lloyd-Jones DM  Statins for Primary Prevention of Cardiovascular Disease-With PREVENT, What's a Clinician to Do?  JAMA  2024 Sep 24;332(12):961-962. doi:10.1001/jama.2024.13887
  21. Pfenniger A, Yoo S, Arora R  Oxidative stress and atrial fibrillation.  J Mol Cell Cardiol  2024 Sep 21;196:141-151. doi:10.1016/j.yjmcc.2024.09.011
  22. Jhund PS, Talebi A, Henderson AD, Claggett BL, Vaduganathan M, Desai AS, Lam CSP, Pitt B, Senni M, Shah SJ  et al.  Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis.  Lancet  2024 Sep 21;404(10458):1119-1131. doi:10.1016/S0140-6736(24)01733-1
  23. Ahmed A, Maisel-Campbell A, Shi VJ, Koza E, Ma M, Haq M, Nadir U, Yi MD, Dave L, Hisham FI  et al.  How Dermatologic Surgeons Decide to Proceed with Surgery for Nonmelanoma Skin Cancer When Site Identification is Initially Uncertain: A Nationwide, Multicenter, Prospective Study.  J Am Acad Dermatol  2024 Sep 20;. pii:S0190-9622(24)02873-1
  24. Pabon MA, Vaduganathan M, Claggett BL, Chatur S, Siqueira S, Marti-Castellote P, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN  et al.  In-hospital course of patients with heart failure with improved ejection fraction in the DELIVER trial.  Eur J Heart Fail  2024 Sep 19;. doi:10.1002/ejhf.3410
  25. Waters EA, Haney CR, Vaught LA, McNally EM, Demonbreun AR  Distribution of MRI-derived T2 values as a biomarker for in vivo rapid screening of phenotype severity in mdx mice.  PLoS One  2024;19(9):e0310551. pii:e0310551
  26. Perry AS, Amancherla K, Huang X, Lance ML, Farber-Eger E, Gajjar P, Amrute J, Stolze L, Zhao S, Sheng Q  et al.  Clinical-transcriptional prioritization of the circulating proteome in human heart failure.  Cell Rep Med  2024 Sep 17;5(9):101704. doi:10.1016/j.xcrm.2024.101704
  27. Lim JS, Lee JJ, Kim GH, Kim HR, Shin DW, Lee KJ, Baek MJ, Ko E, Kim BJ, Kim S  et al.  Subthreshold amyloid deposition, cerebral small vessel disease, and functional brain network disruption in delayed cognitive decline after stroke.  Front Aging Neurosci  2024;16:1430408. pii:1430408
  28. Shah SJ, Sharma K, Borlaug BA, Butler J, Davies M, Kitzman DW, Petrie MC, Verma S, Patel S, Chinnakondepalli KM  et al.  Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials.  Eur Heart J  2024 Sep 14;45(35):3254-3269. doi:10.1093/eurheartj/ehae322
  29. Rothenberger SM, Zhang J, Markl M, Craig BA, Vlachos PP, Rayz VL  4D flow MRI velocity uncertainty quantification.  Magn Reson Med  2024 Sep 13;. doi:10.1002/mrm.30287
  30. Fullenkamp DE, Maeng WY, Oh S, Luan H, Kim KS, Chychula IA, Kim JT, Yoo JY, Holgren CW, Demonbreun AR  et al.  Simultaneous electromechanical monitoring in engineered heart tissues using a mesoscale framework.  Sci Adv  2024 Sep 13;10(37):eado7089. pii:eado7089
  31. Peterson TE, Lima JAC, Shah SJ, Bluemke DA, Bertoni AG, Liu Y, Ngo D, Varadarajan V, Mychaleckyj JC, Johnson CW  et al.  Proteomics of left ventricular structure in the Multi-Ethnic Study of Atherosclerosis.  ESC Heart Fail  2024 Sep 12;. doi:10.1002/ehf2.15073
  32. Vijay A, Huang X, Huffman MD, Kandula NR, Lloyd-Jones DM, Jose PO, Yang E, Goyal A, Khan SS, Shah NS  Myocardial Infarction Quality of Care and Outcomes in Asian Ethnic Groups in the United States.  Circ Cardiovasc Qual Outcomes  2024 Sep 10;:e011097. doi:10.1161/CIRCOUTCOMES.124.011097
  33. Wilkins JT, Ning H, Allen NB, Zheutlin A, Shah NS, Feinstein MJ, Perak AM, Khan SS, Bhatt AS, Shah R  et al.  Prediction of Cumulative Exposure to Atherogenic Lipids During Early Adulthood.  J Am Coll Cardiol  2024 Sep 10;84(11):961-973. doi:10.1016/j.jacc.2024.05.070
  34. Fowler X, Mehta K, Eid M, Gladders B, Kearing S, Moore KO, Creager MA, Austin AM, Feinberg MW, Bonaca MP  et al.  Trends in patient characteristics and mortality among Medicare patients diagnosed with peripheral artery disease.  Vasc Med  2024 Sep 09;:1358863X241262330. doi:10.1177/1358863X241262330
  35. Kosiborod MN, Deanfield J, Pratley R, Borlaug BA, Butler J, Davies MJ, Emerson SS, Kahn SE, Kitzman DW, Lingvay I  et al.  Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials.  Lancet  2024 Sep 07;404(10456):949-961. doi:10.1016/S0140-6736(24)01643-X
  36. Kany S, Jurgens SJ, Rämö JT, Christophersen IE, Rienstra M, Chung MK, Olesen MS, Ackerman MJ, McNally EM, Semsarian C  et al.  Genetic testing in early-onset atrial fibrillation.  Eur Heart J  2024 Sep 07;45(34):3111-3123. doi:10.1093/eurheartj/ehae298
  37. McDermott MM, Dayanidhi S, Leeuwenburgh C, Wohlgemuth SE, Ferrucci L, Peterson CA, Tian L, Sufit R, Zhao L, Slysz J  et al.  The ankle-brachial index, gastrocnemius mitochondrial respirometry, and walking performance in people with and without peripheral artery disease.  Vasc Med  2024 Sep 06;:1358863X241268893. doi:10.1177/1358863X241268893
  38. Culler KL, Sinha A, Filipp M, Giro P, Allen NB, Taylor KD, Guo X, Thorp E, Freed BH, Greenland P  et al.  Metabolomic profiling identifies novel metabolites associated with cardiac dysfunction.  Sci Rep  2024 Sep 05;14(1):20694. pii:20694
  39. Reinstein ZZ, Zhang Y, Ospina OE, Nichols MD, Chu VA, Pulido AM, Prieto K, Nguyen JV, Yin R, Moran Segura C  et al.  Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy.  Cancer Discov  2024 Sep 04;14(9):1631-1652. doi:10.1158/2159-8290.CD-23-0798
  40. Solomon SD, McMurray JJV, Vaduganathan M, Claggett B, Jhund PS, Desai AS, Henderson AD, Lam CSP, Pitt B, Senni M  et al.  Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.  N Engl J Med  2024 Sep 01;. doi:10.1056/NEJMoa2407107
  41. Vaduganathan M, Filippatos G, Claggett BL, Desai AS, Jhund PS, Henderson A, Brinker M, Kolkhof P, Schloemer P, Lay-Flurrie J  et al.  Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes.  Nat Med  2024 Sep 01;. doi:10.1038/s41591-024-03264-4
  42. Trevarrow MP, Munoz MJ, Rivera YM, Arora R, Drane QH, Pal GD, Verhagen Metman L, Goelz LC, Corcos DM, David FJ  Medication improves velocity, reaction time, and movement time but not amplitude or error during memory-guided reaching in Parkinson's disease.  Physiol Rep  2024 Sep;12(17):e16150. pii:e16150
  43. deFilippi CR, Shah P, Shah SJ, Alemayehu W, Lam CSP, Butler J, Roessig L, O'Connor CM, Westerhout CM, Armstrong PW  et al.  Proteomics Identify Clinical Phenotypes and Predict Functional Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF.  Circ Heart Fail  2024 Sep;17(9):e011792. doi:10.1161/CIRCHEARTFAILURE.124.011792
  44. Danna G, Garg R, Buchheit J, Patel R, Zhan T, Ellyn A, Maqbool F, Yala L, Moklyak Y, Frydman J  et al.  Prediction of intra-abdominal injury using natural language processing of electronic medical record data.  Surgery  2024 Sep;176(3):577-585. doi:10.1016/j.surg.2024.05.042
  45. Greenland P, Segal MR, McNeil RB, Parker CB, Pemberton VL, Grobman WA, Silver RM, Simhan HN, Saade GR, Ganz P  et al.  Large-Scale Proteomics in Early Pregnancy and Hypertensive Disorders of Pregnancy.  JAMA Cardiol  2024 Sep 01;9(9):791-799. doi:10.1001/jamacardio.2024.1621
  46. Hu S, Graham RP, Choi WT, Wen KW, Putra J, Chen W, Lin J, Gonzalez IA, Panarelli N, Liu Q  et al.  Clinicopathologic Features of Gastrointestinal Tract Langerhans Cell Histiocytosis.  Mod Pathol  2024 Sep;37(9):100543. doi:10.1016/j.modpat.2024.100543
  47. Ostrominski JW, Aggarwal R, Claggett BL, Kulac IJ, Desai AS, Jhund PS, Lam CSP, Pitt B, Senni M, Shah SJ  et al.  Generalizability of the Spectrum of Kidney Risk in the FINEARTS-HF Trial to U.S. Adults With Heart Failure.  J Card Fail  2024 Sep;30(9):1170-1174. doi:10.1016/j.cardfail.2024.04.015
  48. Dalal PJ, Giro P, Rasmussen-Torvik LJ, Yancy CW, Shah SJ, Reiner AP, Haring B, Martin LW, Wells GL, Manson JE  et al.  Heart Failure Risk Among African-American Women With an ICAM1 Missense Variant.  JACC Heart Fail  2024 Sep;12(9):1614-1624. doi:10.1016/j.jchf.2024.02.002
  49. Docherty KF, Lopez RB, Folkvaljon F, De Boer RA, Cowie MR, Hammarstedt A, Kitzman DW, Kosiborod MN, Langkilde AM, Reicher B  et al.  The Effect of Dapagliflozin on Accelerometer-Based Measures of Physical Activity in Patients with Heart Failure: An Analysis of the DETERMINE Trials.  Circ Heart Fail  2024 Aug 30;. doi:10.1161/CIRCHEARTFAILURE.124.012349
  50. Solomon SD, Ostrominski JW, Wang X, Shah SJ, Borlaug BA, Butler J, Davies MJ, Kitzman DW, Verma S, Abildstrøm SZ  et al.  Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure.  J Am Coll Cardiol  2024 Aug 29;. pii:S0735-1097(24)08192-0